| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.8 |